Apriso

Apriso is a brand name of mesalamine, approved by the FDA in the following formulation(s):

APRISO (mesalamine - capsule, extended release; oral)

• 
  Manufacturer: SALIX PHARMS
  
  Approval date: October 31, 2008
  
  Strength(s): 375MG ^[RLD]

Has a generic version of Apriso been approved?

No. There is currently no therapeutically equivalent version of Apriso available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Apriso. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Pellet formulation for the treatment of the intestinal tract
  Patent 6,551,620
  Issued: April 22, 2003
  Inventor(s): Norbert; Otterbeck
  Assignee(s): Dr. Falk Pharma GmbH
  An orally adminsterable pharmaceutical pellet formulation for the treatment of the intestinal tract is disclosed, which comprises a core and an enteric coating, the core including, as a pharmaceutical active compound, aminosalicylic acid or a pharmaceutically tolerable salt or a derivative thereof.
  
  Patent expiration dates:
  
  
  • April 20, 2018
    
    ✓ 
    Patent use: FOR THE MAINTENANCE OF REMISSION OF ULCERATIVE COLITIS IN SUBJECTS 18 YEARS OF AGE AND OLDER
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • October 31, 2011 - NEW PRODUCT
  
  

See also...

• Apriso Consumer Information (Drugs.com)
• Apriso Extended-Release Capsules Consumer Information (Wolters Kluwer)
• Apriso Consumer Information (Cerner Multum)
• Apriso Advanced Consumer Information (Micromedex)
• Mesalamine Controlled-Release Capsules Consumer Information (Wolters Kluwer)
• Mesalamine Delayed-Release Tablets Consumer Information (Wolters Kluwer)
• Mesalamine Enema Consumer Information (Wolters Kluwer)
• Mesalamine Extended-Release Capsules Consumer Information (Wolters Kluwer)
• Mesalamine Suppositories Consumer Information (Wolters Kluwer)
• Mesalamine Consumer Information (Cerner Multum)
• Mesalamine rectal Consumer Information (Cerner Multum)
• Mesalamine Advanced Consumer Information (Micromedex)
• Mesalamine Rectal Advanced Consumer Information (Micromedex)
• SfRowasa Advanced Consumer Information (Micromedex)
• Mesalamine AHFS DI Monographs (ASHP)